微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[17] 发布: 2013/05/16 19:47:34
Sacramento Bee Previously, it was believed that both the activity and the side-effects of the only approved class of drugs used to treat insulin resistance, thiazolidinedione (TZD) insulin sensitizers, were mediated through PPARg. It is now generally accepted that ... and more »
已读[19] 发布: 2013/05/15 20:59:59
Cedarrepublican As each patient responds differently to medications , the availability of multiple treatment options helps make it possible for health care professionals to create personalized treatment plans for their patients. Three new treatments, NESINA (alogliptin ... and more »
已读[109] 发布: 2013/05/15 16:10:29
、格列奈类药物(瑞格列奈、那格列奈等)、α-糖苷酶抑制剂(如阿卡波糖、米格列...可起到降血糖的作用;通过干细胞的移植,可以增加细胞内运糖蛋白的敏感性,促进...
已读[24] 发布: 2013/05/14 21:00:40
噻唑烷二酮类药物由于其安全性问题,在老年人群中的应用受到了限制。GLP-1类似物和DDP-4抑制剂的出现,老年糖尿病患者的治疗又多了一个有力武器,但尚需积累临床...
已读[17] 发布: 2013/05/14 21:00:38
Cedarrepublican As each patient responds differently to medications , the availability of multiple treatment options helps make it possible for health care professionals to create personalized treatment plans for their patients. Three new treatments, NESINA (alogliptin ... and more »
已读[17] 发布: 2013/05/13 20:56:58
Cedarrepublican As each patient responds differently to medications , the availability of multiple treatment options helps make it possible for health care professionals to create personalized treatment plans for their patients. Three new treatments, NESINA (alogliptin ... and more »
已读[23] 发布: 2013/05/12 20:48:57
药物因素 某些降糖药物及降压药物均可引起水钠潴留,导致下肢浮肿。前者如胰岛素、噻唑烷二酮类药物(如罗格列酮、吡咯列酮);后者如钙离子拮抗剂(如硝苯地平、氨氯...
已读[18] 发布: 2013/05/12 20:48:54
Cedarrepublican As each patient responds differently to medications , the availability of multiple treatment options helps make it possible for health care professionals to create personalized treatment plans for their patients. Three new treatments, NESINA (alogliptin ... and more »
已读[17] 发布: 2013/05/11 20:30:23
Cedarrepublican As each patient responds differently to medications , the availability of multiple treatment options helps make it possible for health care professionals to create personalized treatment plans for their patients. Three new treatments, NESINA (alogliptin ... and more »
已读[19] 发布: 2013/05/10 20:38:29
如UKPDS研究所示,胰岛素治疗12年,患者体重平均增加达8千克;还有研究显示,接受噻唑烷二酮类药物(TZD)治疗,患者5年内体重平均增加4.8千克。 DPP-4抑制剂打开一扇...
« 上一页  |   查看结果471-480共483   |  下一页 »

新闻标签:

没有标签


最新报告


求职招聘